Standard

Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma. / Keulen, Anne-Marleen van; Gaspersz, Marcia P.; van Vugt, Jeroen L. A. et al.

In: Surgery (United States), Vol. 172, No. 6, 12.2022, p. 1606-1613.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

Keulen, A-MV, Gaspersz, MP, van Vugt, JLA, Roos, E, Olthof, PB, Coelen, RJS, Bruno, MJ, van Driel, LMJW, Voermans, RP, van Eijck, CHJ, van Hooft, JE, van Lienden, KP, de Jonge, J, Polak, WG, Poley, J-W, Pek, CJ, Moelker, A, Willemssen, FEJA, van Gulik, TM, Erdmann, JI, Hol, L, IJzermans, JNM, Büttner, S & Koerkamp, BG 2022, 'Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma', Surgery (United States), vol. 172, no. 6, pp. 1606-1613. https://doi.org/10.1016/j.surg.2022.06.028

APA

Keulen, A-M. V., Gaspersz, M. P., van Vugt, J. L. A., Roos, E., Olthof, P. B., Coelen, R. J. S., Bruno, M. J., van Driel, L. M. J. W., Voermans, R. P., van Eijck, C. H. J., van Hooft, J. E., van Lienden, K. P., de Jonge, J., Polak, W. G., Poley, J-W., Pek, C. J., Moelker, A., Willemssen, F. E. J. A., van Gulik, T. M., ... Koerkamp, B. G. (2022). Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma. Surgery (United States), 172(6), 1606-1613. https://doi.org/10.1016/j.surg.2022.06.028

Vancouver

Keulen A-MV, Gaspersz MP, van Vugt JLA, Roos E, Olthof PB, Coelen RJS et al. Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma. Surgery (United States). 2022 Dec;172(6):1606-1613. Epub 2022. doi: 10.1016/j.surg.2022.06.028

Author

Keulen, Anne-Marleen van ; Gaspersz, Marcia P. ; van Vugt, Jeroen L. A. et al. / Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma. In: Surgery (United States). 2022 ; Vol. 172, No. 6. pp. 1606-1613.

BibTeX

@article{5885e67411074658963940ec13e74e9a,
title = "Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma",
abstract = "Background: The patients with unresectable perihilar cholangiocarcinoma require biliary drainage to relieve symptoms and allow for palliative systemic chemotherapy. The aim of this study was to establish the success, complication, and mortality rates of the initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma at presentation. Methods: In this retrospective multicenter study, patients with unresectable perihilar cholangiocarcinoma who underwent initial endoscopic or percutaneous transhepatic biliary drainage between 2002 and 2014 were included. The success of drainage was defined as a successful biliary stent or drain placement, no unscheduled reintervention within 14 days, and serum bilirubin levels <50 μmol/L (ie, 2.9 mg/dL) or a >50% decrease in serum bilirubin after 14 days. Severe complications, and 90-day mortality were recorded. Results: Included were 186 patients: 161 (87%) underwent initial endoscopic biliary drainage and 25 (13%) underwent initial percutaneous transhepatic biliary drainage. The success of initial drainage was observed in 73 patients (45%) after endoscopic biliary drainage and 6 (24%) after percutaneous transhepatic biliary drainage. The reasons for an unsuccessful initial drainage were: the failure to place a drain or stent in 39 patients (21%), an unplanned reintervention within 14 days in 52 patients (28%), and the bilirubin level >50 μmol/L (or not halved) after 14 days of initial drainage in 16 patients (9%). Severe drainage-related complications occurred in 19 patients (12%) after endoscopic biliary drainage and in 3 (12%) after percutaneous transhepatic biliary drainage. Overall, 66 patients (36%) died within 90 days after initial biliary drainage. Conclusion: Initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma had a success rate of 45% and a 90-day mortality rate of 36%. Future studies for patients with perihilar cholangiocarcinoma should focus on improving biliary drainage.",
author = "Keulen, {Anne-Marleen van} and Gaspersz, {Marcia P.} and {van Vugt}, {Jeroen L. A.} and Eva Roos and Olthof, {Pim B.} and Coelen, {Robert J. S.} and Bruno, {Marco J.} and {van Driel}, {Lydi M. J. W.} and Voermans, {Rogier P.} and {van Eijck}, {Casper H. J.} and {van Hooft}, {Jeanin E.} and {van Lienden}, {Krijn P.} and {de Jonge}, Jeroen and Polak, {Wojciech G.} and Jan-Werner Poley and Pek, {Chulja J.} and Adriaan Moelker and Willemssen, {Fran{\c c}ois E. J. A.} and {van Gulik}, {Thomas M.} and Erdmann, {Joris I.} and L. Hol and IJzermans, {Jan N. M.} and Stefan B{\"u}ttner and Koerkamp, {Bas Groot}",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",
year = "2022",
month = dec,
doi = "10.1016/j.surg.2022.06.028",
language = "English",
volume = "172",
pages = "1606--1613",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Success, complication, and mortality rates of initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma

AU - Keulen, Anne-Marleen van

AU - Gaspersz, Marcia P.

AU - van Vugt, Jeroen L. A.

AU - Roos, Eva

AU - Olthof, Pim B.

AU - Coelen, Robert J. S.

AU - Bruno, Marco J.

AU - van Driel, Lydi M. J. W.

AU - Voermans, Rogier P.

AU - van Eijck, Casper H. J.

AU - van Hooft, Jeanin E.

AU - van Lienden, Krijn P.

AU - de Jonge, Jeroen

AU - Polak, Wojciech G.

AU - Poley, Jan-Werner

AU - Pek, Chulja J.

AU - Moelker, Adriaan

AU - Willemssen, François E. J. A.

AU - van Gulik, Thomas M.

AU - Erdmann, Joris I.

AU - Hol, L.

AU - IJzermans, Jan N. M.

AU - Büttner, Stefan

AU - Koerkamp, Bas Groot

N1 - Publisher Copyright: © 2022 The Author(s)

PY - 2022/12

Y1 - 2022/12

N2 - Background: The patients with unresectable perihilar cholangiocarcinoma require biliary drainage to relieve symptoms and allow for palliative systemic chemotherapy. The aim of this study was to establish the success, complication, and mortality rates of the initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma at presentation. Methods: In this retrospective multicenter study, patients with unresectable perihilar cholangiocarcinoma who underwent initial endoscopic or percutaneous transhepatic biliary drainage between 2002 and 2014 were included. The success of drainage was defined as a successful biliary stent or drain placement, no unscheduled reintervention within 14 days, and serum bilirubin levels <50 μmol/L (ie, 2.9 mg/dL) or a >50% decrease in serum bilirubin after 14 days. Severe complications, and 90-day mortality were recorded. Results: Included were 186 patients: 161 (87%) underwent initial endoscopic biliary drainage and 25 (13%) underwent initial percutaneous transhepatic biliary drainage. The success of initial drainage was observed in 73 patients (45%) after endoscopic biliary drainage and 6 (24%) after percutaneous transhepatic biliary drainage. The reasons for an unsuccessful initial drainage were: the failure to place a drain or stent in 39 patients (21%), an unplanned reintervention within 14 days in 52 patients (28%), and the bilirubin level >50 μmol/L (or not halved) after 14 days of initial drainage in 16 patients (9%). Severe drainage-related complications occurred in 19 patients (12%) after endoscopic biliary drainage and in 3 (12%) after percutaneous transhepatic biliary drainage. Overall, 66 patients (36%) died within 90 days after initial biliary drainage. Conclusion: Initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma had a success rate of 45% and a 90-day mortality rate of 36%. Future studies for patients with perihilar cholangiocarcinoma should focus on improving biliary drainage.

AB - Background: The patients with unresectable perihilar cholangiocarcinoma require biliary drainage to relieve symptoms and allow for palliative systemic chemotherapy. The aim of this study was to establish the success, complication, and mortality rates of the initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma at presentation. Methods: In this retrospective multicenter study, patients with unresectable perihilar cholangiocarcinoma who underwent initial endoscopic or percutaneous transhepatic biliary drainage between 2002 and 2014 were included. The success of drainage was defined as a successful biliary stent or drain placement, no unscheduled reintervention within 14 days, and serum bilirubin levels <50 μmol/L (ie, 2.9 mg/dL) or a >50% decrease in serum bilirubin after 14 days. Severe complications, and 90-day mortality were recorded. Results: Included were 186 patients: 161 (87%) underwent initial endoscopic biliary drainage and 25 (13%) underwent initial percutaneous transhepatic biliary drainage. The success of initial drainage was observed in 73 patients (45%) after endoscopic biliary drainage and 6 (24%) after percutaneous transhepatic biliary drainage. The reasons for an unsuccessful initial drainage were: the failure to place a drain or stent in 39 patients (21%), an unplanned reintervention within 14 days in 52 patients (28%), and the bilirubin level >50 μmol/L (or not halved) after 14 days of initial drainage in 16 patients (9%). Severe drainage-related complications occurred in 19 patients (12%) after endoscopic biliary drainage and in 3 (12%) after percutaneous transhepatic biliary drainage. Overall, 66 patients (36%) died within 90 days after initial biliary drainage. Conclusion: Initial biliary drainage in patients with unresectable perihilar cholangiocarcinoma had a success rate of 45% and a 90-day mortality rate of 36%. Future studies for patients with perihilar cholangiocarcinoma should focus on improving biliary drainage.

UR - http://www.scopus.com/inward/record.url?scp=85136111141&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2022.06.028

DO - 10.1016/j.surg.2022.06.028

M3 - Article

C2 - 35989132

VL - 172

SP - 1606

EP - 1613

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 6

ER -

ID: 25832133